Raj-Kumar, Praveen-Kumar
Liu, Jianfang
Soltis, Anthony R.
Bateman, Nicholas W.
Chen, Qingrong
Sturtz, Lori A.
Deyarmin, Brenda
Pierobon, Mariaelena
Abulez, Tamara A.
Praveen-Kumar, Anupama
Zhang, Xijun
Nguyen, Trinh
Yan, Chunhua
Hu, Ying
Guion, Kate
Hooke, Jeffrey A.
Kovatich, Albert J.
Fantacone-Campbell, Leigh
Mostoller, Brad
Kvecher, Leonid
Somiari, Stella
Steeg, Patricia S.
Rajagopal, Padma Sheila
Darcy, Kathleen M.
Lee, Jerry S. H.
Dalgard, Clifton L.
Conrads, Thomas P.
Petricoin, Emanuel F.
Meerzaman, Daoud
Wilkerson, Matthew D.
,
Larson, Caroline
Blackburn, Heather
Miller, Katie
Kane, Jennifer
Cannada, Melissa
Murtha, Kimberly
Sims, Deborah W.
Knapp, Kimberly A.
Kabala, Heather A.
Goins, Erin L.
Tafra, Lorraine
Wareham, Jay
Mullican, Lynn
Joseph, Julie
Wells, Justin M.
Wolf, Nicole L.
Kildee, Margaret M.
Te, Jerez
Viollet, Coralie
Sukumar, Gauthaman
Bacikova, Dagmar
Alba, Camille
McGrath, Elisa
Polisetti, Sraavya
Singh, Jatinder
Adeleye, Adelani
Pollard, Harvey
Mitchell, Dave
Gist, Glenn
Olowu, Victoria
Wilson, Katlin N.
Conrads, Kelly A.
Hood, Brian L.
Makohon-Moore, Sasha
Maxwell, G. Larry
Baldelli, Elisa
Nealeigh, Matthew D.
Cutler, Mary Lou
Russo, Mariano
Zimmer, Alexandra S.
Hanlon, Sean
Lin, Xiaoying
Shriver, Craig D.
Lipkowitz, Stanley
Hu, Hai
Funding for this research was provided by:
Uniformed Services University of the Health Sciences (HU00012220014, HU0001-18-2-0032/4838, HU00012220014, HU0001-18-2-0032/4838)
Intramural Research Program of the National Cancer Institute, National Institutes of Health (ZIA BC 011650)
Article History
Received: 13 December 2024
Accepted: 4 July 2025
First Online: 18 August 2025
Competing interests
: The authors declare no competing interests but the following competing non-financial interests: H.H. is a co-founder and shareholder of miRoncol Diagnostics, Inc.; J.S.H.L. is an unpaid advisory board member of AtlasXomics, Inc., miRoncol Diagnostics, Inc., and ATOM, Inc.